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A B S T R A C T
Background and objectives: Among placental mammals, females undergo immunological shifts during
pregnancy to accommodate the fetus (i.e. fetal tolerance). Fetal tolerance has primarily been character-
ized within post-industrial populations experiencing evolutionarily novel conditions (e.g. reduced
pathogen exposure), which may shape maternal response to fetal antigens. This study investigates
how ecological conditions affect maternal immune status during pregnancy by comparing the direction
and magnitude of immunological changes associated with each trimester among the Tsimane (a sub-
sistence population subjected to high pathogen load) and women in the USA.
Methodology: Data from the Tsimane Health and Life History Project (N¼ 935) and the National
Health and Nutrition Examination Survey (N¼ 1395) were used to estimate population-specific effects
of trimester on differential leukocyte count and C-reactive protein (CRP), a marker of systemic
inflammation.
Results: In both populations, pregnancy was associated with increased neutrophil prevalence, reduced
lymphocyte and eosinophil count and elevated CRP. Compared to their US counterparts, pregnant
Tsimane women exhibited elevated lymphocyte and eosinophil counts, fewer neutrophils and mono-
cytes and lower CRP. Total leukocyte count remained high and unchanged among pregnant Tsimane
women while pregnant US women exhibited substantially elevated counts, resulting in overlapping
leukocyte prevalence among all third-trimester individuals.
Conclusions and implications: Our findings indicate that ecological conditions shape non-pregnant
immune baselines and the magnitude of immunological shifts during pregnancy via developmental
constraints and current trade-offs. Future research should investigate how such flexibility impacts
VC The Author(s) 2020. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.
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maternal health and disease susceptibility, particularly the degree to which chronic pathogen exposure might dampen inflammatory re-
sponse to fetal antigens.
Lay Summary: This study compares immunological changes associated with pregnancy between the Tsimane (an Amazonian subsist-
ence population) and individuals in the USA. Results suggest that while pregnancy enhances non-specific defenses and dampens both
antigen-specific immunity and parasite/allergy response, ecological conditions strongly influence immune baselines and the magnitude
of shifts during gestation.
K E Y W O R D S : reproductive ecology; fetal tolerance; ecological immunology; Tsimane
INTRODUCTION
Among placental mammals, female reproduction requires hosting
genetically non-identical offspring throughout gestation without
rejecting fetal tissue—a phenomenon termed fetal tolerance [1]. In
humans (as well as chimpanzees and gorillas), placentation is par-
ticularly invasive [2, 3] and fetal tolerance requires systemic
changes in maternal immune function that alter susceptibility to
certain infections and autoimmune disorders [4–7]. To date, fetal
tolerance has been studied primarily in high-income post-indus-
trial countries, such as the USA and the UK, where epidemiologic-
al transitions over the past several centuries have largely curbed
exposure to numerous parasites, pathogens and microbes other-
wise abundant throughout human history prior to industrialization
[8, 9]. Such microbial deprivation lowers overall infectious disease
mortality but provides fewer opportunities for immune calibration,
paving the way for immunological hypersensitivity to non-
pathogenic stimuli and development of myriad chronic inflamma-
tory disorders (e.g. allergy, rheumatoid arthritis) common across
industrialized populations [10]. The potential effects of impaired
immune calibration on maternal responses to fetal antigens likely
interact with other common and evolutionarily novel aspects of
post-industrial societies, such as elevated rates of obesity (a
chronic inflammatory state) [11] and low parity (which results in
less ‘exposure’ to fetal antigens over time). Considering the cur-
rent characterization of fetal tolerance is primarily derived from
populations experiencing such ecological conditions, understand-
ing of how fetal tolerance is shaped by environments more closely
resembling those experienced throughout most of human evolu-
tion and by many women alive today is limited.
From both an evolutionary perspective and a public health stand-
point, there is a pressing need to examine the effect of pregnancy
on maternal immunity across diverse environments, particularly
those characterized by elevated infection risk. To this end, this study
estimates and compares the effect of pregnancy on differential
leukocyte count and C-reactive protein (CRP) concentration among
Tsimane women, a natural-fertility subsistence population inhabit-
ing a pathogen-rich environment, and women in the USA (Table 1).
Maternal immune changes during pregnancy
In humans and other mammalian species with haemochorial
placentation, gestation results in exposure to both fetal cells [12]
and cell-free fetal DNA [13], prompting systemic recalibration of
maternal immune function and changes in maternal disease
susceptibility [14]. During pregnancy, women are generally
more vulnerable to intracellular pathogens [4] but exhibit ele-
vated resistance to extracellular microbes [5]. Pregnancy also
exerts contrasting effects on autoimmunity: certain auto-
immune diseases, such as rheumatoid arthritis, temporarily re-
solve during gestation [15] while others worsen [16]. These
alterations in disease susceptibility have been linked to quanti-
tative shifts in immune components, though the underlying
causal pathways are only partially elucidated. Pregnancy is often
described as a state of regulated inflammation [17] and is con-
sistently marked by a rise in the total number of circulating leu-
kocytes [18], primarily due to expansion of neutrophils and
monocytes [19]. Neutrophils and monocytes are phagocytic
cells that induce inflammatory activation and strengthen resist-
ance to extracellular infections, but are also implicated in the
etiology of autoimmune diseases [20] and deleterious
inflammation-mediated conditions, such as preterm birth [21].
Total lymphocyte counts are consistently reduced during preg-
nancy, primarily due to fewer circulating cytotoxic lymphocytes
capable of directly recognizing and targeting fetal antigens [22,
23]. Conversely, proliferation of regulatory lymphocytes is
heightened [24], further moderating the response to fetal anti-
gens. Eosinophils mediate parasitic and allergic responses and
are often reduced among pregnant women [25], though the role
of pregnancy-induced eosinopenia is relatively understudied.
Taken together, these patterns (based primarily on cross-
sectional studies of women in high-income industrialized coun-
tries) suggest that pregnancy induces heavier reliance on non-
specific defenses and down-regulation of antigen-specific im-
munity and immune components involved in allergy/parasite
response, thereby facilitating fetal tolerance while preserving
general pathogen defense.
Immune function among the Tsimane
The Tsimane inhabit the Bolivian neo-tropics, an environment
rich in biodiversity and home to myriad infectious agents. Due
to varied and chronic exposure, infections (largely respiratory
and gastrointestinal) are the primary drivers of morbidity and
mortality among the Tsimane, while allergies, atopy and
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autoimmune diseases are rare [26]. At any given time, the ma-
jority of Tsimane individuals are infected with at least one spe-
cies of helminth, and over a third are infected with giardia [27].
Furthermore, Tsimane women have restricted access to contra-
ception and the average total fertility rate is nine births per
woman [28]. On average, the Tsimane exhibit developmental
trajectories in which energetic investment is preferentially
shunted into overall immune function, resulting in higher rest-
ing metabolic rate and total energy expenditure [29], reduced
growth [30] and elevated baseline levels of most immunological
parameters compared to Western clinical standards [31].
Average leukocyte counts are higher among the Tsimane, due
to more circulating lymphocytes, neutrophils and eosinophils.
On average, eosinophil counts are 7 higher among Tsimane
individuals compared to current Western clinical standards,
presumably reflecting chronic exposure to multicellular para-
sites, whereas basophil and monocyte counts are lower and
might reflect greater recruitment of these cells out of circulation
into localized sites of infection [31]. Acute inflammation, meas-
ured by CRP, is roughly comparable between US and Tsimane
adults aged 18–49, although the etiology differs: among the
Tsimane, inflammation is primarily driven by infection, whereas
obesity, cigarette smoking and chronic inflammatory disorders
(e.g. Type 2 diabetes) are larger contributors to low-grade
chronic inflammation in the US population [31].
Predictions
Considering how the immunological demands of fetal tolerance
and pathogen defense may collide in the pathogen-rich, re-
source-restricted environment currently inhabited by the
Tsimane, we suggest three possible scenarios. Scenario 1:
Tsimane women may experience less pregnancy-induced
changes in immune function than do US women, potentially
compromising fetal tolerance to maintain pathogen resistance.
In this case, we would expect that the estimated effects of
pregnancy on leukocyte (i.e. WBC) differential and CRP would
be comparatively smaller in magnitude among the Tsimane.
Scenario 2: Tsimane women may experience similar changes in
immunity to women in less pathogenic conditions, thus experi-
encing greater infection risk at the cost of maintaining fetal tol-
erance. Under this scenario, both the direction and magnitude
of the estimated effects of pregnancy on immune status should
be comparable between populations. Scenario 3: Tsimane
women may compensate for the dual burden of fetal tolerance
and infection by preferentially elevating defenses which are less
likely to specifically target fetal antigens (e.g. non-specific im-
munity). In this context, pregnancy should correspond to a dis-
proportionate increase in markers of non-specific immunity
(e.g. neutrophils, monocytes and CRP) compared to degree of
down-regulation of antigen-specific immune function (e.g. total
lymphocyte count).
METHODOLOGY
Tsimane health and life history project dataset
Mixed cross-sectional and longitudinal data were collected from
2004 to 2014 as part of the ongoing Tsimane Health and Life
History Project (THLHP; http://tsimane.anth.ucsb.edu/index.
html, (13 July 2020, date last accessed)) [27, 31–33]. Pregnancy
status was determined during medical visits based on date of
last menses, with urinary pregnancy tests administered by the
physician when pregnancy was suspected. Pregnancies were
cross-validated against subsequent annual demographic and
census interviews that ascertained children’s birth dates, per-
mitting detection of pregnancies occurring between medical vis-
its and pregnancies that went undetected during previous
physician examinations [33].
Venous blood drawn into heparinized vacutainers was ana-
lyzed immediately after collection. Total leukocyte counts were
determined with a QBC Autoread Plus dry hematology system
Table 1. General descriptions of immunological biomarkers used in this study
Total leukocytes The total number of nucleated immune cells circulating in the blood, also known as WBC count.
Lymphocytes A heterogenous group of cells identified based on the presence of CD45 receptors. Made up of T,
B and Natural Killer cells that together mediate antigen-specific immunity.
Neutrophils Abundant phagocytic granulocytes that respond to extracellular and fungal infection, prime the adap-
tive response and promote inflammation.
Monocytes Phagocytic granulocytes, similar in function to neutrophils but shorter-lived and less prevalent in the
blood. Migrate to sites of infection where they differentiate into tissue-specific macrophages.
Eosinophils Granulocytes involved in parasite response and allergy. Chronically elevated in populations where
parasite exposure is high.
Basophils A rare type of granulocyte involved in inflammation and parasite response.
CRP Non-specific acute-phase reactant released by the liver in response to inflammation.
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(QBC Diagnostics) and relative fractions of neutrophils, eosino-
phils, lymphocytes, basophils and monocytes were determined
manually by microscopy with a hemocytometer. Blood drawn
into serum vacutainers was allowed to clot and then centrifuged
to separate serum, which was frozen in liquid nitrogen and then
transported on dry ice for analysis at the University of
California, Santa Barbara (UCSB). Serum samples were then
analyzed to determine CRP concentration at the UCSB Human
Biodemography lab via enzyme immunoassay (ELISA) [34],
using a protocol validated against the same University of
Washington lab responsible for NHANES data analyses [31].
For this study, the THLHP dataset included pregnant and
non-pregnant cycling women aged 18–45 years with total and
differential leukocyte count (WBC) and/or CRP concentration.
Non-pregnant women who were not regularly menstruating due
to either lactational amenorrhea or menopause were excluded
from analyses. Given these inclusion criteria, the initial THLHP
sample contained 1198 observations (cycling N¼ 942; pregnant
N¼ 256). The number of pregnant women sampled was lower
than the number of cycling women, and pregnant participants
were, on average, younger than cycling women. Based on previ-
ously reported Tsimane interbirth intervals and THLHP over-
sampling of people over age 40 during some rounds of data
collection, this initial sampling distribution roughly followed the
expected 3:1 ratio of cycling to pregnant participants. To ad-
dress potential sampling biases, we randomly selected a subset
of cycling women from the initial dataset with an age-
distribution matching that of the pregnant subset. We did this
by dividing the pregnant subset into 6-year age groups and
using the sample function in R to pick a proportional sample of
cycling women from each age bracket. Since not all individuals
had recorded data for both CRP and WBC, we conducted this
age-matching process separately for participants with complete
WBC differential data and those with CRP data. Across the final
aggregated dataset used for this study, slightly more individuals
were sampled during the second and third trimester compared
to the first, although not more than would be expected by
chance (v2 ¼ 3.66, df ¼ 2, P> 0.1). Pregnant and cycling
Tsimane women exhibited comparable body mass index (BMI)
(t ¼ 0.73, df ¼ 497.01, P-value ¼ 0.46), while median parity
(i.e. number of live births) was higher among pregnant women
(t ¼ 3.20, df ¼ 454.55, P-value <0.01).
Although median parity was comparatively lower within the
cycling sample, this was likely due to the mixed cross-sectional
and longitudinal nature of the THLHP collection schedule ra-
ther than disproportionate sampling of individuals with undiag-
nosed fertility issues. Based on the ratio of Tsimane women
experiencing lactational amenorrhea to those who are currently
pregnant (at any given age), lactational amenorrhea usually
lasts between 12 and 14 months. Considering the average inter-
birth interval in this population is 30 months [28], these
estimates indicate that most Tsimane women experience 7 to
9 months of regular cycling between each pregnancy. In our en-
tire sample of non-pregnant cycling Tsimane women, the me-
dian number of recorded live births was 4 (range ¼ 0–11),
providing further evidence that by-and-large these individuals
were simply in-between pregnancies when these particular data
were collected. Only 88 out of 727 total observations in the
cycling sample belonged to nulliparous individuals, and of
these the majority belonged to individuals who were under the
age of 25. In total, only 3% of non-pregnant regularly cycling
Tsimane women in our sample were both nulliparous and over
the age 25, suggesting that our findings are not skewed by dis-
proportionate sampling of women with undiagnosed infertility.
For complete descriptive statistics, see Table 2.
NHANES dataset
We compiled data from NHANES (2003–16) (https://wwwn.
cdc.gov/nchs/nhanes/, (14 July 2020, date last accessed)), lim-
iting our sample to pregnant and cycling women between ages
18 and 45 years with complete data on WBC differential and/or
CRP concentration. To ensure as comparable of a selection pro-
cess as possible between THLHP and NHANES samples, indi-
viduals in the NHANES dataset were included in the cycling
group if they were not pregnant or breastfeeding at the time of
the study, reported having regular menstrual cycles throughout
the last year, and were not currently using hormonal contracep-
tion. No exclusions were based on medical diagnoses. CRP was
measured using nephelometry, while total and differential
leukocyte counts were measured using the Coulter method. All
participants in the NHANES dataset were measured only once.
According to these inclusion criteria and dataset characteristics,
the initial NHANES dataset selected for this study contained
1652 observations (cycling N¼ 1375; pregnant N¼ 277). The
same method used to age-match groups within the THLHP
dataset was utilized to age-match cycling and pregnant subsets
within the NHANES dataset, for both WBC differential and CRP
subsamples. Pregnancy was determined by participant report or
urine test at the time of exam, which may explain why women in
their first trimester were significantly under-sampled relative to
women in later pregnancy (v2 ¼ 25.15, df ¼ 2, P< 0.001).
Overall, pregnant US women exhibited higher BMI (t ¼ 2.59,
df ¼ 490.17, P-value <0.01) and lower median parity (t ¼
13.91, df ¼ 487.45, P-value <0.001) than non-pregnant
women. For complete descriptive statistics, see Table 2.
Given population-level differences in age (t ¼ 13.73, df ¼
1460.40, P-value <0.001), BMI (t¼ 18.41, df ¼ 1957.40, P-value
<0.001) and parity (t ¼ 36.27, df ¼ 1107.40, P-value <0.001),
we did not attempt to match sampling distributions across pop-
ulations, as this would have substantially reduced our overall
sample for analysis. Instead, we controlled for age, BMI and
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parity in all statistical models. The final dataset is available at
https://doi.org/10.25349/D94C77, (14 July 2020, date last
accessed).
Statistical analyses
All analyses were conducted in R 3.6.2 (https://cran.r-project.
org/, (14 July 2020, date last accessed)) using the brms package
[35]. For each outcome variable, we estimated the population-
specific effects of reproductive status (i.e. non-pregnant cycling,
trimester 1, trimester 2 or trimester 3), adjusting for fixed-
effects of age, BMI and parity and, when applicable, a random
effect of participant ID, to account for repeated measures per
participant in the mixed cross-sectional and longitudinal
THLHP sample. Due to population-specific differences in im-
mune marker distributions, THLHP and NHANES eosinophil
count, monocyte count and monocyte proportion were modeled
separately using discrete priors and different distribution fami-
lies. Among the Tsimane, raw eosinophil counts were log-
transformed and then estimated using a Gaussian model, while
eosinophil counts among US women followed a negative bino-
mial distribution and were modeled as such. Monocyte counts
among Tsimane women included excess zeroes and were there-
fore approximated using a zero-inflated Poisson model, while
monocyte counts among US women were log-transformed and
estimated using a Gaussian distribution. All other biomarkers
were distributed similarly across populations and were there-
fore modeled together, with population as a model term and tri-
mester:population as the interaction term. Gaussian models
were used to estimate all log-transformed measures following a
normal distribution (i.e. CRP, total leukocyte count, neutrophil
count and proportion, lymphocyte count and proportion) while
zero-inflated Poisson models were used for biomarkers with ex-
cess zero counts (i.e. basophil count). In both populations, eo-
sinophil percentage was log-left-skewed and was modeled
using a skew-normal distribution following log-transformation.
Median values and 5th and 95th quantiles for all outcome
variables in each reproductive state were estimated using age-,
parity- and BMI-standardized posterior population distributions
(Table 3). Delta values, both between populations for each
Table 2. Descriptive statistics indicating median value and range (in parentheses) for age, BMI and
parity (number of live births), as well as number of repeat samples and total sample size for each popula-
tion, reproductive status and data subset (leukocyte differential/CRP)
Subset Population Descriptive Cycling T1 T2 T3
Leukocyte differential NHANES Age 27 (20–44) 25 (18–41) 27 (19–40) 28 (18–39)
THLHP 32 (18–45) 32 (18–45) 29 (18–45) 34 (18–45)
NHANES BMI 26 (15–73) 26 (17–67) 27 (19–57) 30 (21–57)
THLHP 24 (17–36) 23 (17–31) 23 (19–37) 25 (19–33)
NHANES Parity 0 (0, 3) 2 (0, 3) 1 (0, 3) 2 (1, 3)
THLHP 4 (0, 10) 6 (1, 11) 5 (0, 11) 6 (1, 11)
NHANES RM 0 0 0 0
THLHP 149 1 3 6
NHANES N 1060 (71.41% np) 52 107 108
THLHP 662 (13.14% np) 70 94 91
CRP NHANES Age 27 (20–45) 25 (18–41) 27 (19–43) 28 (18–39)
THLHP 38 (18–45) 38 (21–44) 37 (22–43) 40 (19–42)
NHANES BMI 26 (15–73) 26 (17–67) 27 (19–57) 30 (21–57)
THLHP 24 (19–37) 22 (21–29) 25 (22–32) 26 (23–30)
NHANES Parity 0 (0, 3) 2 (0, 3) 1 (0, 3) 1 (1, 3)
THLHP 6 (0, 11) 7 (2, 12) 8 (3, 10) 8 (1, 12)
NHANES RM 0 0 0 0
THLHP 0 0 0 0
NHANES N 476 (69.75% np) 53 113 110
THLHP 65 (10.77% np) 10 11 8
Total NHANES N 1536 105 220 218
THLHP 727 80 105 99
‘% np’ indicates percent of nulliparous individuals within sample.
T1, trimester 1; T2, trimester 2; T3, trimester 3.
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reproductive state (Table 3) and between reproductive states
within each population (Table 4), were calculated as the differ-
ence between standardized posterior parameter distributions,
with the exception of basophil and monocyte counts and pro-
portions, which were calculated as the difference between
standardized posterior population distributions to account for
excess zeros. When reporting results, posterior distributions on
log scales were exponentiated to return them to the linear scale
of the original measures. Estimated fixed-effects of age, parity
and BMI for each outcome variable are provided in Table 5.
RESULTS
Total leukocyte counts overlap among second and third
trimester Tsimane and US women, despite Tsimane
women having substantially elevated non-pregnant
baselines
Non-pregnant cycling Tsimane women had, on average, 34.8%
(CI ¼ 30.8%, 38.6%) or 2439 cells/ml (CI ¼ 2182, 2690) more
circulating leukocytes than their US peers—reflecting elevated
baseline immune activation (Table 3). Among US women, first,
second and third trimester leukocyte counts were increased
over non-pregnant baseline by 15.1% (CI ¼ 7.8%, 22.8%),
31.1% (CI ¼ 24.9%, 37.1%) and 29.2% (CI ¼ 23.2%, 34.9%), re-
spectively (Table 4). In contrast, there was no appreciable vari-
ation in leukocyte count among Tsimane women attributable to
reproductive state. As a result, leukocyte counts did not differ
significantly between Tsimane and US women in the second
and third trimester (Table 3 and Fig. 1).
Pregnant women in both populations exhibit elevated
neutrophil counts, reduced lymphocytes and fewer
eosinophils than non-pregnant women, but the magnitude
of these differences varies by trimester and population
Neutrophils. Neutrophil counts among cycling Tsimane
women were 22.0% (CI ¼ 17.5%, 26.8%) or 872 cells/ml (CI ¼
704, 1049) higher than cycling US women (Table 3). Within the
US sample, women in the first, second and third trimester pos-
sessed neutrophil counts that were elevated over non-pregnant
baseline by 30.3% (CI ¼ 19.5%, 41.3%), 65.0% (CI ¼ 55.5%,
74.4%) and 63.0% (CI ¼ 53.7%, 72.9%), respectively (Table 4).
Pregnancy was also associated with elevated neutrophil counts
among Tsimane women, although the magnitude of this rela-
tionship was relatively attenuated: neutrophil counts were
increased by 8.4% (CI ¼ 0.3%, 16.7%), 19.3% (CI ¼ 11.6%,
27.5%) and 20.5% (CI ¼ 12.5%, 28.4%) among first, second
and third trimester Tsimane women (Table 4). Consequently,
average neutrophil counts among second and third trimester
Tsimane women were 758 (CI ¼ 260, 1289) and 652 (CI ¼ 107,Ta
b
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1170) cells/ml lower than those exhibited by US women (Table 3
and Fig. 1).
Lymphocytes. Lymphocyte counts among non-pregnant
Tsimane women were 26.1% (CI ¼ 21.8%, 30.5%) or 568 cells/
ml (CI ¼ 479, 659) greater than those observed among cycling
US women (Table 3). Within the US sample, first, second and
third trimester lymphocyte counts were reduced by 10.0% (CI ¼
3.6%, 15.9%), 15.7% (CI ¼ 11.0%, 20.1%) and 22.8% (CI ¼
18.6%, 26.7%) compared to non-pregnant baselines (Table 4).
Among Tsimane women, there was also a negative relationship
between trimester and lymphocyte count: second and third tri-
mester lymphocyte counts were reduced by 21.3% (CI ¼ 16.7%,
25.9%) and 21.2% (CI ¼ 16.5%, 25.5%), respectively (Table 4
and Fig. 1).
Eosinophils. Eosinophil counts among cycling Tsimane
women were 555.1% (CI ¼ 490.9%, 630.7%) or 1016 cells/ml
(CI ¼ 914, 1139) higher than cycling women in the USA
(Table 3). Among US women, there was a negative relationship
between eosinophil count and pregnancy progression, with
counts unchanged in the first trimester, but reduced by 17.0%
(CI ¼ 2.1%, 29.5%) in the second trimester and 19.8% (CI ¼
5.0%, 32.4%) in the third trimester (Table 4). Among Tsimane
women, first trimester eosinophil counts did not significantly
differ from cycling, while second and third trimester counts
were 22.0% (CI ¼ 7.7%, 34.3%) and 41.7% (CI ¼ 30.3%,
51.1%) lower than non-pregnant baseline, respectively (Table 4
and Fig. 1). Regardless of these greater percent reductions from
cycling, third trimester eosinophils remained 379.3% (CI ¼
272.3%, 515.4%) higher in Tsimane women than US women.
Monocytes. Among Tsimane women, monocyte counts did
not vary by reproductive state and remained consistently lower
than those among US women (Table 3). Within the US sample,
monocyte counts in the first, second and third trimester counts
Table 4. Model-estimated delta values (D) for leukocyte counts and CRP, by trimester and population
Measure Population Unit T1–cycling D T2–cycling D T3–cycling D
Total leukocytes NHANES cells/ml 1058 (552, 1591) 2183 (1756, 2594) 2048 (1641, 2448)
% 15.1% (7.8%, 22.8%) 31.1% (24.9%, 37.1%) 29.2% (23.2%, 34.9%)
THLHP cells/ml 285 (277, 838) 121 (596, 364) 350 (805, 118)
% 3.0% (2.9%, 8.9%) 1.3% (6.3%, 3.9%) 3.7% (8.5%, 1.3%)
Neutrophils NHANES cells/ml 1203 (781, 1637) 2580 (2210, 2941) 2500 (2141, 2886)
% 30.3% (19.5%, 41.3%) 65.0% (55.5%, 74.4%) 63.0% (53.7%, 72.9%)
THLHP cells/ml 410 (13, 815) 934 (561, 1319) 989 (613, 1372)
% 8.4% (0.3%, 16.7%) 19.3% (11.6%, 27.5%) 20.5% (12.5%, 28.4%)
Lymphocytes NHANES cells/ml 219 (348, 78) 343 (441, 238) 497 (585, 402)
% 10.0% (15.9%, 3.6%) 15.7% (20.1%, 11.0%) 22.8% (26.7%, 18.6%)
THLHP cells/ml 73 (254, 101) 584 (717, 455) 580 (705, 448)
% 2.7% (9.2%, 3.7%) 21.3% (25.9%, 16.7%) 21.2% (25.5%, 16.5%)
Eosinophils NHANES cells/ml 8 (31, 55) 31 (55, 4) 37 (60, 9)
% 4.2% (17.0%, 30.3%) 17.0% (29.5%, 2.1%) 19.8% (32.4%, 5.0%)
THLHP cells/ml 87 (142, 364) 264 (421, 93) 499 (635, 353)
% 7.2% (11.9%, 30.1%) 22.0% (34.3%, 7.7%) 41.7% (51.1%, 30.3%)
Monocytes NHANES cells/ml 45 (4, 85) 49 (20, 81) 105 (72, 138)
% 9.0% (0.9%, 17.3%) 10.0% (4.0%, 16.5%) 21.2% (14.6%, 28.1%)
THLHP cells/ml 0 (132, 164) 0 (133, 89) 0 (133, 122)
Basophils NHANES cells/ml 0 (110, 110) 0 (110, 115) 0 (110, 108)
THLHP cells/ml 0 (0, 0) 0 (0, 0) 0 (0, 0)
CRP NHANES mg/l 2.49 (1.61, 3.54) 3.66 (2.81, 4.62) 2.04 (1.50, 2.66)
% 169.0% (105.9%, 244.7%) 247.2% (184.6%, 318.0%) 137.7% (98.0%, 184.2%)
THLHP mg/l 2.45 (0.67, 5.85) 2.73 (0.95, 5.84) 0.26 (0.58, 1.80)
% 180.7% (46.1%, 436.6%) 199.3% (65.1%, 447.3%) 19.1% (38.2%, 138.8%)
For each trimester, delta was calculated as the difference from non-pregnant cycling. Estimated median, 5th and 95th percentiles for delta values were
estimated as the difference between parameter distributions, with the exception of THLHP monocytes and NHANES and THLHP basophils, which
were calculated using the difference between posterior population distributions to include excess zero values.
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were increasingly elevated above cycling baseline by 9.0% (CI ¼
0.9%, 17.3%), 10.0% (CI ¼ 4.0%, 16.5%) and 21.2% (CI ¼
14.6%, 28.1%) (Table 4 and Fig. 1).
Basophils. In both populations, basophil count remained low
and did not vary by reproductive state (Tables 3 and 4; Fig. 1).
Population-specific differences in immune cell counts
produce variation in leukocyte proportions
Among cycling Tsimane women, total leukocyte count com-
prised 51.1% neutrophils (CI ¼ 38.0%, 68.9%), 28.8% lympho-
cytes (CI ¼ 19.2%, 43.9%), 15.1% eosinophils (CI ¼ 5.7%,
33.3%) and <1% monocytes and basophils (Table 3). In com-
parison, leukocyte counts among cycling US women comprised
56.4% neutrophils (CI ¼ 41.9%, 76.7%), 30.7% lymphocytes
(CI ¼ 20.1%, 47.4%), 7.5% monocytes (CI ¼ 4.9%, 11.6%),
3.2% eosinophils (CI ¼ 1.2%, 7.1%) and <1% basophils
(Table 3 and Fig. 2).
Neutrophils. In both populations neutrophil proportions were
increasingly elevated by trimester, peaking at 71.8% (CI ¼
53.6%, 95.6%) among US women and 64.4% (CI ¼ 47.7%,
86.5%) among Tsimane women (Table 3 and Fig. 2). Across all
reproductive states, US women displayed greater neutrophil
proportions than Tsimane women (Table 3).
Lymphocytes. Pregnancy progression was associated with
declining lymphocyte proportions among both Tsimane and US
women, though Tsimane individuals exhibited higher lympho-
cyte proportions across all three trimesters. Lymphocyte percen-
tages reached population-specific lows of 23.3% (CI ¼ 15.0%,
35.8%) for Tsimane women in the second trimester and 18.6%
(CI ¼ 12.3%, 29.1%) for US women in the third trimester
(Table 3 and Fig. 2).
Eosinophils. Later pregnancy was associated with reduced eo-
sinophil proportions among the Tsimane, reaching a third-
trimester low of 9.5% (CI ¼ 3.5%, 20.8%). Among US women,
pregnancy progression was associated with a comparatively
small decrease in eosinophil proportion, reaching a third-
trimester low of 2.3% (CI ¼ 0.9%, 5.4%) (Table 3 and Fig. 2).
Monocytes and basophils. In both populations, basophil and
monocyte proportions were low and did not vary substantially
by reproductive state (Table 3 and Fig. 2).
Early pregnancy is associated with inflammatory activation
in both populations, but only US women retain elevated
inflammation in late pregnancy
Among cycling women, CRP concentration did not differ sub-
stantially across populations (Table 3). Among US women in
the first, second and third trimester, CRP was elevated by
169.0% (CI ¼ 105.9%, 244.7%), 247.2% (CI ¼ 184.6%, 318.0%)
and 137.7% (CI ¼ 98.0%, 184.2%), respectively (Table 4).
Among Tsimane women, CRP in the first and second trimester
was elevated by 180.7% (CI ¼ 46.1%, 436.6%) and 199.3% (CI
Table 5. Median and 5% and 95% confidence intervals (in parentheses) for the estimated fixed-effects
of age, BMI and parity for all models
Measure Units Age BMI Parity
Total leukocytes ln (cells/ml) 0.001 (0.003, 0.001) 0.009 (0.007, 0.010) 0.004 (0.009, 0.001)
Neutrophils ln (cells/ml) 0.001 (0.003, 0.001) 0.011 (0.009, 0.013) 0.009 (0.016, 0.002)
Lymphocytes ln (cells/ml) 0.003 (0.005, 0.001) 0.007 (0.006, 0.009) 0.000 (0.006, 0.006)
Eosinophils (THLHP) ln (cells/ml) 0.014 (0.004, 0.024) 0.006 (0.023, 0.011) 0.003 (0.028, 0.021)
Eosinophils (NHANES) cells/ml 0.008 (0.017, 0.001) 0.005 (0.000, 0.011) 0.009 (0.028, 0.047)
Monocytes (THLHP) cells/ml 0.022 (0.024, 0.020) 0.023 (0.019, 0.026) 0.056 (0.051, 0.061)
Monocytes (NHANES) ln (cells/ml) 0.001 (0.004, 0.002) 0.003 (0.001, 0.005) 0.033 (0.047, 0.021)
Basophils cells/ml 0.007 (0.006, 0.009) 0.013 (0.013, 0.014) 0.036 (0.041, 0.030)
% Neutrophils ln (% cells/ml) 0.000 (0.001, 0.001) 0.002 (0.001, 0.003) 0.005 (0.009, 0.002)
% Lymphocytes ln (% cells/ml) 0.002 (0.004, 0.000) 0.002 (0.003, 0.000) 0.004 (0.002, 0.009)
% Eosinophils ln (% cells/ml) 0.001 (0.002, 0.005) 0.003 (0.005, 0.000) 0.017 (0.007, 0.027)
% Monocytes (NHANES) ln (% cells/ml) 0.001 (0.004, 0.001) 0.006 (0.007, 0.004) 0.021 (0.031, 0.011)
% Monocytes (THLHP) % cells/ml 0.020 (0.002, 0.038) 0.017 (0.012, 0.045) 0.002 (0.044, 0.042)
% Basophils % cells/ml 0.011 (0.004, 0.025) 0.001 (0.008, 0.010) 0.004 (0.057, 0.061)
CRP ln (mg/l) 0.000 (0.012, 0.011) 0.085 (0.077, 0.092) 0.036 (0.006, 0.078)
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¼ 65.1%, 447.3%), while third trimester CRP largely overlapped
with baseline concentrations (Table 4). Consequently, third tri-
mester Tsimane women displayed CRP concentrations that
were, on average, 54.1% (CI ¼ 6.7%, 75.8%) or 1.89 mg/l (CI ¼
0.25, 2.85) lower than their third trimester US counterparts
(Table 3 and Fig. 3).
Reduced models excluding BMI and parity predict even
greater magnitude of population-level differences in total
leukocyte and neutrophil count and CRP concentration
To further evaluate the contribution of BMI and parity to
between-population differences in immune markers across re-
productive states, we compared the predicted values for total
Figure 1. Total leukocyte, neutrophil, lymphocyte, eosinophil, monocyte and basophil counts among Tsimane (blue) and US women (orange) in each repro-
ductive state. Raw data are represented by density curves, while dots indicate model-estimated median values standardized by age, BMI and parity. C, non-
pregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3. All y-axes are natural logged but are on different scales
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leukocyte, neutrophil, lymphocyte, eosinophil and monocyte
count and CRP concentration generated by our full models
(which included age, parity and BMI and trimester:population as
interaction term) with those produced by reduced models,
which omitted BMI and parity as covariates. Models excluding
BMI and parity predicted higher values for total leukocytes, neu-
trophils and CRP among US women and lower values for total
leukocyte and neutrophil counts among Tsimane individuals,
resulting in heightened estimated population-level differences
across reproductive states for these measures. Removing
effects of BMI and parity produced largely unchanged predicted
values for lymphocyte, eosinophil and monocyte counts
(Supplementary Table S1 and Fig. S1). Taken together, these
results indicate that the ‘true’ differences in total leukocyte and
neutrophil count and CRP between US and Tsimane women are
partially due to BMI and parity but cannot be fully explained by
these factors.
DISCUSSION
These results provide strong evidence that the immunology of
pregnancy, a unique physiological state involving exposure to
fetal antigens, consistently follows overarching patterns of
modulation across diverse human populations but is also influ-
enced by local ecological conditions. Elevated leukocyte count,
currently considered a reliable clinical marker of pregnancy pro-
gression [17,36], was replicated in our US sample but was not
observed among Tsimane women, who exhibited high leukocyte
counts regardless of reproductive phase. Pregnancy was strong-
ly associated with increased neutrophil counts, reduced lym-
phocytes and fewer eosinophils in both populations, suggesting
heavier reliance on non-specific immune defenses and down-
regulation of antigen-specific immunity across diverse
ecologies. However, although population-specific effects of
pregnancy on leukocyte subsets were in the same direction,
Tsimane women retained greater absolute and relative lympho-
cyte and eosinophil counts and showed lower absolute and rela-
tive neutrophil and monocyte prevalence, irrespective of
trimester. Acute systemic inflammation, measured by CRP, was
elevated among pregnant women in the first two trimesters in
both populations, which is consistent with previous reports
suggesting that pregnancy is a controlled state of inflammation
[17, 37]. Yet our results also indicate that, when compared to
US women, Tsimane women undergo relatively less change in
inflammatory activation across gestation, particularly in the
third trimester.
Absence of pregnancy-induced leukocytosis, comparatively
low neutrophil and monocyte counts, and relatively attenuated
acute inflammation among pregnant Tsimane women may be
due in part to strong constraints imposed by infection risk and
competing demands on energy distribution. Among the
Tsimane, 10% of all fetal deaths are attributed to maternal in-
fection [38]. While there are surprisingly few data on the rate of
infection-induced miscarriages in the USA, many infectious dis-
eases with the greatest impact on miscarriage risk (e.g. malaria,
Dengue fever) are endemic to the Amazonian region and rela-
tively rare in high-income post-industrial contexts, suggesting
maternal infection poses a proportionally greater threat to preg-
nancy among the Tsimane [39, 40]. In addition, infection with
hookworm (an intestinal parasite endemic to the Amazon) is
associated with older age of first birth and reduced lifetime fer-
tility among Tsimane women [33], possibly as a result of con-
flicting immunological demands during pregnancy [7].
Maintaining elevated immune activation and sustaining preg-
nancy are metabolically costly processes [29, 41], especially in
resource-restricted environments where infection risk is high
Figure 2. Leukocyte proportions among Tsimane (blue) and US women (orange) across reproductive states. Raw data are represented by density curves, while
dots indicate model-estimated median values standardized by age, BMI and parity. C, non-pregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3
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[42]. Under such constraints, Tsimane women may retain rela-
tively greater investment in lymphocyte and eosinophil cell pop-
ulations during pregnancy as a strategy to contend with
ongoing exposure to quickly evolving pathogens and parasitic
invaders [31], necessitating comparatively tempered neutrophil
and monocyte proliferation and systemic inflammation despite
potential costs (e.g. bacterial infections).
Another interpretation of our findings is that Tsimane women
may be, in certain aspects, better primed for pregnancy than
their US counterparts. While the Tsimane contend with high in-
fectious disease morbidity and mortality, pathogen exposure
also provides benefits, namely finer immunological calibration
that safeguards against autoreactivity and hypersensitivity [8]. It
stands to reason that this protective effect extends to encoun-
ters with fetal antigens during pregnancy, thus dampening
responsivity—especially in terms of inflammatory processes.
Chronic infection with parasites that induce similar states of im-
munological tolerance may especially attune the maternal im-
mune system for pregnancy [43]. Infection with roundworm
(Ascaris lumbricoides), a low-virulence intestinal parasite that sti-
fles host inflammation, has already been linked to earlier age of
first reproduction and higher lifetime fertility among Tsimane
women [33], providing preliminary support for this perspective.
In contrast, exposure to fetal antigens may prompt exaggerated
and potentially deleterious inflammatory activation among
women in the USA, where opportunities for immune calibration
are comparatively scarce. This interpretation is bolstered by our
observation that acute systemic inflammation was higher
among US women in later pregnancy, a phase of gestation
marked by increasing exposure to cell-free fetal DNA [13].
Figure 3. CRP concentration among Tsimane (blue) and US women (orange) by reproductive status. Raw data are represented by density curves. Dots indi-
cate model-estimated median values and error bars represent model-estimated 5th and 95th confidence intervals, all standardized for age, BMI and parity. C,
non-pregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3. y-Axis is natural logged
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Comparatively elevated investment in neutrophils among preg-
nant US women could also indicate a greater skew toward in-
flammatory activation, considering neutrophils often initiate
and amplify inflammatory cascades [ 44]. However, pregnancy-
induced neutrophil expansion could also be a compensatory
mechanism tempering responsivity to fetal antigens, consider-
ing neutrophils are also capable of inducing regulatory T cell
phenotypes during pregnancy [45].
Limitations and future directions
While our findings provide clear evidence that ecological vari-
ation impacts both non-pregnant immune profiles and im-
munological investment strategies during pregnancy, the
underlying causal pathways and consequences remain points of
speculation. Future research should employ longitudinal study
designs to definitively link variation in the expression of fetal tol-
erance with maternal and infant outcomes, as this approach
would allow for a better understanding of how much variation
stems from differences in immune calibration and how much
can be attributed to localized constraints and trade-offs. Given
that there are documented individual and population-level dif-
ferences in placental morphology [46], with more invasive pla-
centation associated with higher levels of cell-free fetal DNA
[47], it is theoretically possible that our findings could be related
to population-level differences in fetal antigen exposure stem-
ming from differences in fetal size and/or placental phenotype.
To further explore this possibility, future studies would benefit
from a closer consideration of how levels of cell-free fetal DNA
and placental phenotype might affect maternal immune pro-
files, particularly across ecologically distinct populations. Along
a similar vein, we were not able to account for potential
population-level differences in hematological parameters (e.g.
blood viscosity, plasma volume), which have been found to vary
across other ecological clines (e.g. high versus low altitude)
[48]. Considering increased blood viscosity during pregnancy
could place functional limits on the number of circulating im-
mune cells, documenting and accounting for hematological
profile would be a useful addition to future studies. Subsequent
research would also benefit from evaluating the effects of preg-
nancy and environment on a wider breadth of immune bio-
markers. Due to dataset restrictions, we were limited to
quantifying large-scale differences in immune cell populations
and a singular measure of acute inflammation (with a small
THLHP sample size), excluding other relevant and more fine-
grained indices of immune function (e.g. cytokine profiles, pro-
portion of regulatory T cells, neutrophil oxidative bursts). Lastly,
while the ecological landscape currently inhabited by Tsimane
women presumably more closely resembles the environmental
conditions that prevailed before the agricultural transition and
industrialization, the Tsimane do not serve as a universal
representation of other past or contemporary non-industrialized
populations. Rather, this study highlights the need for future
studies to consider variation both across and within non-
industrialized contexts, especially since myriad factors combine
to produce mosaic ecologies. The USA itself encompasses
underappreciated and understudied disparity in environmental
circumstances; numerous so-called ‘Third World’ diseases re-
main endemic in certain rural areas [49] and disproportionately
affect marginalized communities within urban centers [50].
Future research on populations where infectious disease bur-
den remains elevated but where the immunoregulatory benefits
are obscured by processed diets, physical inactivity and other
adverse consequences of ‘modernization’ may yield particularly
fruitful insight into how interactions between environmental
factors influence maternal immune profiles across reproductive
states.
CONCLUSIONS AND IMPLICATIONS
To our knowledge, this is the first study to estimate the effects
of pregnancy on female immune status in a non-industrialized
context and the first to directly compare expressions of fetal tol-
erance between two ecologically distinct populations. Our
results replicate previous findings that pregnancy is not a state
of immunosuppression, but rather a period of dynamic immune
modulation generally favoring non-specific defenses and down-
regulated antigen-specific immunity and parasite response.
While these overarching patterns appear to be shared across
populations, this study provides evidence that immunological
profiles during pregnancy vary in response to ecology, with
pregnant Tsimane women exhibiting comparatively elevated in-
vestment in lymphocyte and eosinophil cell populations, rela-
tively smaller neutrophil and monocyte counts, and attenuated
acute inflammatory activation. These findings likely reflect steep
trade-offs between fetal tolerance, pathogen defense and energy
restriction among the Tsimane, but could also indicate that
Tsimane women benefit from comparatively reduced inflamma-
tory activation and stronger resistance to intracellular patho-
gens across gestation. Future research is needed to parse out
the potential benefits of pathogen exposure in moderating
responses to fetal antigens and the constraints imposed by on-
going disease risk and resource budgeting. While such ques-
tions remain, this study is an important first step in
acknowledging that the immunology of successful pregnancy is
not a one-size-fits-all phenomenon. In sum, our findings add
nuance to the current understanding of ‘normal’ pregnancy and
will hopefully prompt further consideration of ecological vari-
ability both across and within populations, especially as it per-
tains to maternal health and disease.
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Supplementary data are available at EMPH online.
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22. Kühnert M, Strohmeier R, Stegmüller M et al. Changes in lymphocyte
subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol
1998;76:147–51.
23. Matthiesen L, Berg G, Ernerudh J et al. Lymphocyte subsets and mito-
gen stimulation of blood lymphocytes in normal pregnancy. Am J
Reprod Immunol 1996;35:70–9.
24. Somerset DA, Zheng Y, Kilby MD et al. Normal human pregnancy is
associated with an elevation in the immune suppressive CD25 þ CD4
þ regulatory T-cell subset. Immunology 2004;112:38–43.
25. Pitkin R M. Platelet and Leukocyte Counts in Pregnancy. JAMA: The
Journal of the American Medical Association 1979; 242:2696
10.1001/jama.1979.03300240036023.
26. Gurven M, Kaplan H, Supa AZ. Mortality experience of Tsimane
Amerindians of Bolivia: regional variation and temporal trends. Am J
Hum Biol 2007;19:376–98.
27. Martin M, Blackwell AD, Gurven M et al. Make new friends and keep
the old? Parasite coinfection and comorbidity in homo sapiens. In: JF
Brinkworth, K Pechenkina (eds). Primates, Pathogens, and Evolution.
New York, NY: Springer New York, 2013, 363–87.
28. McAllister L, Gurven M, Kaplan H et al. Why do women have more chil-
dren than they want? Understanding differences in women’s ideal and
actual family size in a natural fertility population. Am J Hum Biol 2012;
24:786–99.
29. Gurven MD, Trumble BC, Stieglitz J et al. High resting metabolic rate
among Amazonian forager-horticulturalists experiencing high pathogen
burden. Am J Phys Anthropol 2016;161:414–25.
Flexibility of fetal tolerance Hové et al. | 127
30. Blackwell AD, Urlacher SS, Beheim B et al. Growth references for
Tsimane forager-horticulturalists of the Bolivian Amazon. Am J Phys
Anthropol 2017;162:441–61.
31. Blackwell AD, Trumble BC, Maldonado Suarez I et al. Immune function
in Amazonian horticulturalists. Ann Hum Biol 2016;43:382–96.
32. Gurven M, Stieglitz J, Trumble B et al. The Tsimane Health and Life
History Project: integrating anthropology and biomedicine. Evol
Anthropol 2017;26:54–73.
33. Blackwell AD, Tamayo MA, Beheim B et al. Helminth infection, fecund-
ity, and age of first pregnancy in women. Science (80-) 2015;350:970–9.
34. Brindle E, Fujita M, Shofer J et al. Serum, plasma, and dried blood spot
high-sensitivity C-reactive protein enzyme immunoassay for population
research. J Immunol Methods 2010;362:112–20.
35. Bürkner P-C. brms: an R Package for Bayesian multilevel models using
Stan. J Stat Softw 2017;80:1–27, DOI: 10.18637/jss.v080.i01.
36. Arbib N, Aviram A, Gabbay Ben-Ziv R et al. The effect of labor and deliv-
ery on white blood cell count. J Matern Neonatal Med 2015;29:1–8.
37. Mei Z, Li H, Serdula MK et al. C-reactive protein increases with gesta-
tional age during pregnancy among Chinese women. Am J Hum Biol
2016;28:574–9.
38. Gurven M. Infant and fetal mortality among a high fertility and mortal-
ity population in the Bolivian Amazon. Soc Sci Med 2012;75:2493–502.
39. Tauil PL. The status of infectious disease in the Amazon region. Emerg
Infect Dis 2009;15:625.
40. Giakoumelou S, Wheelhouse N, Cuschieri K et al. The role of infection
in miscarriage. Hum Reprod Update 2016;22:116–33.
41. Butte NF, King JC. Energy requirements during pregnancy and lacta-
tion. Public Health Nutr 2005;8:1010–27.
42. McDade TW, Reyes-Garcı́a V, Tanner S et al. Maintenance versus
growth: investigating the costs of immune activation among children
in lowland Bolivia. Am J Phys Anthropol 2008;136:478.
43. King IL, Li Y. Host–parasite interactions promote disease tolerance to
intestinal helminth infection. Front Immunol 2018;9:1–10.
44. Amulic B, Cazalet C, Hayes GL et al. Neutrophil function: from mecha-
nisms to disease. Annu Rev Immunol 2012;30:459–89.
45. Nadkarni S, Smith J, Sferruzzi-Perri AN et al. Neutrophils induce proan-
giogenic T cells with a regulatory phenotype in pregnancy. Proc Natl
Acad Sci 2016;113:E8415–24.
46. Rutherford JN, deMartelly VA, Ragsdale HB et al. Global population
variation in placental size and structure: evidence from Cebu,
Philippines. Placenta 2019;85:40–8.
47. Sekizawa A, Jimbo M, Saito H et al. Increased cell-free fetal DNA in
plasma of two women with invasive placenta. Clin Chem 2002;48:353–4.
48. Kametas NA, Krampl E, McAuliffe F et al. Pregnancy at high altitude: a
hyperviscosity state. Acta Obstet Gynecol Scand 2004;83:627–33.
49. Mckenna ML, Mcatee S, Bryan PE et al. Human Intestinal parasite bur-
den and poor sanitation in Rural Alabama. Am J Trop Med Hyg 2017;
97:1623–8.
50. Leibler JH, Zakhour CM, Gadhoke P et al. Zoonotic and vector-borne
infections among urban homeless and marginalized people in the
United States and Europe, 1990–2014. Vector Borne Zoonotic Dis
2016;16:435–44.
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